LUBRICANT EYE DROPS SOLUTION- polyethylene glycol 400 and propylene glycol solution 
AvPAK

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Lubricant Eye Drops Solution

Active IngredientsPurpose
Polyethylene Glycol 400 0.4%Lubricant
Propylene Glycol 0.3%Lubricant

Uses

  • For the temporary relief of burning, irritation and discomfort due to dryness of the eye and exposure to wind or sun.
  • May be used as a protectant against further irritation.

Warnings

For use in the eyes only

Do not use

  • If solution changes color or becomes cloudy.

When using this product

  • avoid contamination, do not touch tip of container to any surface
  • replace cap after use

Stop use and ask a doctor if

  • you experience eye pain, changes in vision, continued redness or irritation of the eye
  • the condition worsens or persists for more than 72 hours

Keep this and all drugs out of the reach of children.

If swallowed, get medical help or contact a Poison Control Center right away (1-800-222-1222)

Directions

  • shake well before use
  • instill 1 or 2 drops in the affected eye(s) as needed

Other Information

  • store at room temperature 15°- 30°C (59°-86°F).
  • do not use if imprinted seal on cap is torn, broken or missing
  • discard 90 days after opening
  • retain outer carton for full product information

Inactive Ingredients:

Benzalkonium chloride (preservative), boric acid, calcium chloride, hypromellose, magnesium chloride, potassium chloride, purified water, sodium chloride, zinc chloride. May contain hydrochloric acid and/or sodium hydroxide to adjust pH.

Questions?

1-855-361-3993

Distributed by:

AvKARE

Pulaski, TN 38478

www.avkare.com

Rev. 12/2022 AV 12/2022

PRINCIPAL DISPLAY PANEL

15

LUBRICANT EYE DROPS SOLUTION 
polyethylene glycol 400 and propylene glycol solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:50268-126
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ) (POLYETHYLENE GLYCOL 400 - UNII:B697894SGQ) POLYETHYLENE GLYCOL 4004 mg  in 1 mL
PROPYLENE GLYCOL (UNII: 6DC9Q167V3) (PROPYLENE GLYCOL - UNII:6DC9Q167V3) PROPYLENE GLYCOL3 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
BORIC ACID (UNII: R57ZHV85D4)  
CALCIUM CHLORIDE (UNII: M4I0D6VV5M)  
MAGNESIUM CHLORIDE (UNII: 02F3473H9O)  
POTASSIUM CHLORIDE (UNII: 660YQ98I10)  
WATER (UNII: 059QF0KO0R)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
ZINC CHLORIDE (UNII: 86Q357L16B)  
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:50268-126-151 in 1 CARTON02/25/2003
115 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34902/25/2003
Labeler - AvPAK (832926666)

Revised: 2/2023
 
AvPAK